Growth Metrics

Merck (MRK) Assets Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.08%
Dec 31, 2025 7.83%
Sep 30, 2025 6.55%
Jun 30, 2025 3.15%
Mar 31, 2025 2.57%
Dec 31, 2024 3.48%
Sep 30, 2024 7.93%
Jun 30, 2024 7.49%
Mar 31, 2024 5.23%
Dec 31, 2023 5.21%
Sep 30, 2023 5.93%
Jun 30, 2023 4.86%
Mar 31, 2023 8.28%
Dec 31, 2022 8.95%
Sep 30, 2022 8.72%
Jun 30, 2022 8.45%
Mar 31, 2022 9.01%
Dec 31, 2021 8.55%
Sep 30, 2021 3.17%
Jun 30, 2021 2.17%
Mar 31, 2021 1.83%
Dec 31, 2020 1.39%
Sep 30, 2020 -0.69%
Jun 30, 2020 -0.79%
Mar 31, 2020 -4.19%
Dec 31, 2019 -3.99%
Sep 30, 2019 -5.37%
Jun 30, 2019 -4.52%
Mar 31, 2019 -5.87%
Dec 31, 2018 -6.68%
Sep 30, 2018 -5.61%
Jun 30, 2018 -6.06%
Mar 31, 2018 -7.40%
Dec 31, 2017 -3.63%
Sep 30, 2017 -3.43%
Jun 30, 2017 -1.75%
Mar 31, 2017 -3.80%
Dec 31, 2016 -3.35%
Sep 30, 2016 -2.60%
Jun 30, 2016 -3.36%
Dec 31, 2015 -1.42%
Jun 30, 2015 -0.94%
Mar 31, 2015 0.89%
Dec 31, 2014 -2.26%
Sep 30, 2014 -1.50%
Jun 30, 2014 -2.69%
Mar 31, 2014 0.81%
Dec 31, 2013 -0.04%
Sep 30, 2013 -0.44%
Jun 30, 2013 0.22%
Dec 31, 2012 -1.87%
Jun 30, 2012 52.86%